GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...
3d
Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
2024 — Scientists have identified promising real-world links between common HIV drugs and a reduced incidence of Alzheimer's ... Scientists Identify Pro-Aging 'Sugar Signature' in the Blood of ...
It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus ...
The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...
Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...
It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus ...
The Centers for Disease Control and Prevention provides funding for HIV prevention for the populations at the highest risk of ...
It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are ...
People with HIV can safely receive donated kidneys from deceased donors with the virus, according to a large study that comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback